Cardiopulmonary exercise testing variables as predictors of long-term outcome in thoracic sarcoidosis

Brazilian Journal of Medical and Biological Research

Volumn 45, Issue 3, 2012, Pages 256-263

  Lopes, A J ^a,b   Menezes, S L S ^b,c   Dias, C M ^b   Oliveira, J F ^b   Mainenti, M R M ^b   Guimaraes F S ^b,c  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Centro Universitario Augusto Motta   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Exercise; Respiratory function tests; Respiratory mechanics; Sarcoidosis

Indexed keywords

CARBON MONOXIDE;

ARTICLE; BREATHING RATE; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; EVALUATION; FEMALE; FOLLOW UP; FORCED VITAL CAPACITY; HUMAN; LONGITUDINAL STUDY; LUNG ALVEOLUS OXYGEN TENSION; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; MALE; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; SARCOIDOSIS; SPIROMETRY; THORACIC SARCOIDOSIS;

EID: 84858406827     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2012007500018     Document Type: Article

References (26)

1. Abehsera M, Valeyre D, Grenier P, Jaillet H, Battesti JP, Brauner MW. Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function. AJR Am J Roentgenol 2000; 174: 1751-1757.
2. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-755.
3. Marciniuk DD, Gallagher CG. Clinical exercise testing in interstitial lung disease. Clin Chest Med 1994; 15: 287-303.
4. Weisman IM, Zeballos RJ. Clinical exercise testing. Clin Chest Med 2001; 22: 679-701, viii.
5. Xaubet A, Rodriguez-Roisin R, Bombi JA, Marin A, Roca J, Augusti-Vidal A. Correlation of bronchoalveolar lavage and clinical and functional findings in asbestosis. Am Rev Respir Dis 1986; 133: 848-854.
6. Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation. Br Med J 1961; 2: 1165-1172.
7. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152: 1107-1136.
8. Medinger AE, Khouri S, Rohatgi PK. Sarcoidosis: the value of exercise testing. Chest 2001; 120: 93-101.
9. Pereira CA, Sato T, Rodrigues SC. New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol 2007; 33: 397-406.
10. Neder JA, Andreoni S, Peres C, Nery LE. Reference values for lung function tests. III. Carbon monoxide diffusing capacity (transfer factor). Braz J Med Biol Res 1999; 32: 729-737.
11. Sietsema KE, Kraft M, Ginzton L, Sharma OP. Abnormal oxygen uptake responses to exercise in patients with mild pulmonary sarcoidosis. Chest 1992; 102: 838-845.
12. Gibbons WJ, Levy RD, Nava S, Malcolm I, Marin JM, Tardif C, et al. Subclinical cardiac dysfunction in sarcoidosis. Chest 1991; 100: 44-50.
13. Barros WG, Neder JA, Pereira CA, Nery LE. Clinical, radiographic and functional predictors of pulmonary gas exchange impairment at moderate exercise in patients with sarcoidosis. Respiration 2004; 71: 367-373.
14. Neder JA, Nery LE, Castelo A, Andreoni S, Lerario MC, Sachs A, et al. Prediction of metabolic and cardiopulmonary responses to maximum cycle ergometry: a randomised study. Eur Respir J 1999; 14: 1304-1313.
15. Baughman RP, Shipley R, Eisentrout CE. Predictive value of gallium scan, angiotensin-converting enzyme level, and bronchoalveolar lavage in two-year follow-up of pulmonary sarcoidosis. Lung 1987; 165: 371-377.
16. Judson MA, Baughman RP, Thompson BW, Teirstein AS, Terrin ML, Rossman MD, et al. Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 204-211.
17. Baughman RP, Nagai S, Balter M, Costabel U, Drent M, du Bois R, et al. Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force. Sarcoidosis Vasc Diffuse Lung Dis 2011; 28: 56-64.
18. Winterbauer RH, Hutchinson JF. Use of pulmonary function tests in the management of sarcoidosis. Chest 1980; 78: 640-647.
19. Lamberto C, Nunes H, Le Toumelin P, Duperron F, Valeyre D, Clerici C. Membrane and capillary blood components ofdiffusion capacity of the lung for carbon monoxide in pulmonary sarcoidosis: relation to exercise gas exchange. Chest 2004; 125: 2061-2068.
20. Arena R, Sietsema KE. Cardiopulmonary exercise testing in the clinical evaluation of patients with heart and lung disease. Circulation 2011; 123: 668-680.
21. Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164: 1885-1889.
22. Miller A, Brown LK, Sloane MF, Bhuptani A, Teirstein AS. Cardiorespiratory responses to incremental exercise in sarcoidosis patients with normal spirometry. Chest 1995; 107: 323-329.
23. Marciniuk DD, Watts RE, Gallagher CG. Dead space loading and exercise limitation in patients with interstitial lung disease. Chest 1994; 105: 183-189.
24. Eklund A, Broman L, Broman M, Holmgren A. V/Q and alveolar gas exchange in pulmonary sarcoidosis. Eur Respir J 1989; 2: 135-144.
25. Arcasoy SM, Christie JD, Pochettino A, Rosengard BR, Blumenthal NP, Bavaria JE, et al. Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. Chest 2001; 120: 873-880.
26. Kollert F, Geck B, Suchy R, Jorres RA, Arzt M, Heidinger D, et al. The impact of gas exchange measurement during exercise in pulmonary sarcoidosis. Respir Med 2011; 105: 122-129.